Fundraising Fox

Neochord

Maple Grove, US · Founded 2007 · Delaware corporation · 16 employees on LinkedIn · 3 known investors

NeoChord develops a medical device system for beating heart mitral valve repair in patients with mitral valve regurgitation. The company's flagship product, the NeoChord Artificial Chordae Delivery System, has received CE market clearance in Europe.

Advanced ManufacturingHealthtechMedical Devices

Founders & leadership

TB
Todd BergExecutive
DH
David H. ChungExecutive
RN
Ron NelsonExecutive

Board

CTCasey Tansey
Casey TanseyBoard directorGeneral Partner at US Venture Partners
MK
Mudit K. JainBoard director
AEAndrew ElBardissi
Andrew ElBardissiin𝕏Board MemberPartner at Deerfield Management Company
ML
Michael LiangBoard director
JA
J. Alex MartinBoard director

Investors · 3

Treo Ventures, LlcMinneapolis
US Venture PartnersMenlo Park · $500K – $10Mvia Casey Tansey · board
Deerfield Management CompanyreportedNew Yorkvia Andrew ElBardissi · board

Reported raises · per SEC filings

Form D private placements

$64.9M disclosed across 11 rounds · 2015–2025

▶$493.2KraisedMar 2025 · 14 investors · Manufacturing
Rule 506(b)
Officers, directors & promoters on the filing
  • Mudit K. JainDirector
  • Casey TanseyDirector
  • Todd BergExecutive Officer, Director
Offering amount
$2.1M
Amount sold
$493.2K
First sale
Feb 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$914.3KraisedAug 2024 · 9 investors · Manufacturing
Rule 506(b)
Officers, directors & promoters on the filing
  • Casey TanseyDirector
  • Mudit K. JainDirector
  • Todd BergExecutive Officer, Director
Offering amount
$2.9M
Amount sold
$914.3K
First sale
Aug 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.6MraisedJul 2023 · 3 investors · Manufacturing
Rule 506(b)
Officers, directors & promoters on the filing
  • David NeustaedterDirector
  • Ron NelsonExecutive Officer
  • J. Alex MartinDirector
  • David H. ChungExecutive Officer, Director
  • Mudit K. JainDirector
  • Casey TanseyDirector
  • David GregorkaDirector
Offering amount
$6.8M
Amount sold
$4.6M
First sale
Jun 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.9MraisedNov 2022 · 25 investors · Manufacturing
Rule 506(b)
Officers, directors & promoters on the filing
  • Ron NelsonExecutive Officer
  • Casey TanseyDirector
  • David GregorkaDirector
  • David H. ChungExecutive Officer, Director
  • J. Alex MartinDirector
  • Andrew ElBardissiDirector
  • Mudit K. JainDirector
Offering amount
$6M
Amount sold
$2.9M
First sale
Sep 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.8MraisedMar 2022 · 6 investors · Manufacturing
Rule 506(b)
Officers, directors & promoters on the filing
  • J. Alex MartinDirector
  • Michael LiangDirector
  • David H. ChungExecutive Officer, Director
  • Andrew ElBardissiDirector
  • Casey TanseyDirector
  • Mudit K. JainDirector
  • Ron NelsonExecutive Officer
Offering amount
$3.5M
Amount sold
$1.8M
First sale
Feb 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1MraisedSep 2021 · 6 investors · Manufacturing
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael LiangDirector
  • Mudit K. JainDirector
  • Andrew ElBardissiDirector
  • Casey TanseyDirector
  • Ron NelsonExecutive Officer
  • David H. ChungExecutive Officer, Director
  • J. Alex MartinDirector
Offering amount
$4M
Amount sold
$1M
First sale
Sep 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.8MraisedMay 2021 · 6 investors · Manufacturing
Rule 506(b)
Officers, directors & promoters on the filing
  • J. Alex MartinDirector
  • Mudit K. JainDirector
  • Andrew ElBardissiDirector
  • Casey TanseyDirector
  • David H. ChungExecutive Officer, Director
  • Ron NelsonExecutive Officer
  • Michael LiangDirector
Offering amount
$3.9M
Amount sold
$2.8M
First sale
Apr 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$33.4MraisedFeb 2021 · 28 investors · Manufacturing
Rule 506(b)
Officers, directors & promoters on the filing
  • Casey TanseyDirector
  • J. Alex MartinDirector
  • Nicole J. WalkerDirector
  • Andrew ElBardissiDirector
  • Mudit K. JainDirector
  • David H. ChungExecutive Officer, Director
  • Ron NelsonExecutive Officer
Offering amount
$33.5M
Amount sold
$33.4M
First sale
Oct 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

NeoChord Raises Additional Financing to Drive Catheter‐based Program Development, Bringing Total Series D Funding to over $32 Million | NeoChordneochord.com · Apr 2019NeoChord Raises Additional $7M in Series D Financing - FinSMEsfinsmes.com · Apr 2019NeoChord Raises Additional Financing to Drive Catheter-based Program Development, Bringing Total Series D Funding to over $32 Millionglobenewswire.com · Apr 2019NeoChord raises $25m in Series D - MassDevicemassdevice.com · Nov 2018News - USVP/usvp.com · Feb 2017NeoChord receives $850,000 - Global Venturingglobalventuring.com · Dec 2012

Frequently asked questions

What does Neochord do?
NeoChord develops a medical device system for beating heart mitral valve repair in patients with mitral valve regurgitation. The company's flagship product, the NeoChord Artificial Chordae Delivery System, has received CE market clearance in Europe.
Who are Neochord's investors?
Neochord's investors include Treo Ventures, Llc, US Venture Partners, Deerfield Management Company.
How much funding has Neochord raised?
Neochord has disclosed $64.9M raised across 11 rounds.
Where is Neochord headquartered?
Neochord is headquartered in Maple Grove, US.